NuBloom review
Six dose strengths are listed on the product page and every one of them costs the same.
The verdict
NuBloom publishes $149 a month for compounded semaglutide, on a month-to-month subscription. Six dose strengths are listed at that figure. Coverage is 49 states.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 49
- From
- From $149/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 49 states
NuBloom sells both molecules by injection. Doses of 0.25, 0.5, 1, 1.7, 2 and 2.4 mg are listed. A BMI of 27 or above is required.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The BMI threshold is published. The clinician is not described.
Listing every dose beside one price answers the escalation question without a ladder. A reader can see the top of the range and what it costs.
What happens when the dose goes up?
This is answered plainly. Six strengths run from 0.25 to 2.4 mg at the same monthly figure. Nothing describes clinical support at a step.
What the price includes
Six months at $149 is $894 and that total holds at any listed dose. Tirzepatide is $249 on a microdose product page, which is a narrower plan than the semaglutide line. Both are month to month.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Six dose strengths listed with one price
- Strength: Coverage recorded across 49 states
- Strength: Month to month on both lines
- Strength: The BMI threshold is published
- Limitation: The tirzepatide line is a microdose product
- Limitation: One state is not served
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about NuBloom. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants the top dose priced before starting the lowest.
- Wrong for
- A reader wanting a full-dose tirzepatide plan.
The evidence behind what NuBloom prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How NuBloom compares
| Seller | Who it suits | Go |
|---|---|---|
| A reader paying from an FSA or HSA who will ask to be quoted a real figure | See Nucore Health → | |
| Readers who value a site that agrees with itself | See Obu Health → | |
| Readers wanting an oral semaglutide at the injection price | See NuDay Rx → |
More GLP-1 telehealth sellers reviews: RoboclinicRoen RxRX BellaRx.comRxION HealthRxPepsDirect
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Does the price change by dose?
- No. Six strengths from 0.25 to 2.4 mg are listed at $149 a month.
- Is the tirzepatide line the same?
- No. It is a microdose product at $249 a month.
- Is there a BMI requirement?
- Yes. A BMI of 27 or above is stated.
- Is NuBloom legit?
- NuBloom is a GLP-1 telehealth sellers service. Its stated availability: 49 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is NuBloom expensive compared with other GLP-1 telehealth sellers?
- NuBloom publishes a starting figure of $149/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts NuBloom below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.